Koen Andries
Koen Andries is a Belgian Janssen Pharmaceutica scientist and professor at the University of Antwerp. In 2005 he and his team published a discovery about a new di-Aryl-Quinoline-based drug (R207910), now called bedaquiline, which promises a shorter and simpler treatment for drug resistant Tuberculosis (TB).
Link from a Wikipage to another Wikipage
primaryTopic
Koen Andries
Koen Andries is a Belgian Janssen Pharmaceutica scientist and professor at the University of Antwerp. In 2005 he and his team published a discovery about a new di-Aryl-Quinoline-based drug (R207910), now called bedaquiline, which promises a shorter and simpler treatment for drug resistant Tuberculosis (TB).
has abstract
Koen Andries (...) è un profes ...... ce rispetto al comune placebo.
@it
Koen Andries is a Belgian Jans ...... g resistant Tuberculosis (TB).
@en
Koen Andries is een Belgische ...... ine bij Janssen Pharmaceutica.
@nl
alma mater
nationality
state of origin
Link from a Wikipage to an external page
Wikipage page ID
15,098,968
page length (characters) of wiki page
Wikipage revision ID
961,753,411
Link from a Wikipage to another Wikipage
alma mater
name
Koen Andries
@en
nationality
occupation
Janssen Pharmaceutica and professor at the University of Antwerp
@en
wikiPageUsesTemplate
subject
comment
Koen Andries (...) è un profes ...... ce rispetto al comune placebo.
@it
Koen Andries is a Belgian Jans ...... g resistant Tuberculosis (TB).
@en
Koen Andries is een Belgische ...... ine bij Janssen Pharmaceutica.
@nl
label
Koen Andries
@en
Koen Andries
@it
Koen Andries
@nl
wasDerivedFrom
isPrimaryTopicOf
name
Koen Andries
@en